{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:38:00Z","timestamp":1792715880041,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.esmoop.2026.108528","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:12:45Z","timestamp":1788538365000},"page":"108528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anatomical location defines distinct molecular subtypes of mucosal melanoma"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4363-211X","authenticated-orcid":false,"given":"E.-R.","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0676-1826","authenticated-orcid":false,"given":"J.","family":"Rusheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ariyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-6510","authenticated-orcid":false,"given":"S.","family":"Gabizon-Peretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.esmoop.2026.108528_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/cancers14030780","article-title":"Epidemiology and molecular profile of mucosal melanoma: a population-based study in Southern Europe","volume":"14","author":"Carb\u00f3-Bagu\u00e9","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108528_bib2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/annonc\/mdw694","article-title":"The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively followed patients","volume":"28","author":"Lian","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108528_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1200\/JCO.2016.67.9258","article-title":"Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis","volume":"35","author":"D\u2019Angelo","year":"2017","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108528_bib4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/cancers15051541","article-title":"Trends in incidence and survival of 1496 patients with mucosal melanoma in The Netherlands (1990-2019)","volume":"15","author":"Boer","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108528_bib5","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1038\/s41467-019-11107-x","article-title":"Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets","volume":"10","author":"Newell","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108528_bib6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1158\/1541-7786.MCR-20-0839","article-title":"Meta-analysis and systematic review of the genomics of mucosal melanoma","volume":"19","author":"Broit","year":"2021","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108528_bib7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1186\/s12885-018-4977-2","article-title":"Predominance of triple wild-type and IGF2R mutations in mucosal melanomas","volume":"18","author":"Iida","year":"2018","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108528_bib8","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1002\/cam4.3789","article-title":"Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade","volume":"10","author":"Buchbinder","year":"2021","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108528_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/CMR.0000000000000345","article-title":"Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma","volume":"27","author":"Hintzsche","year":"2017","journal-title":"Melanoma Res"},{"key":"10.1016\/j.esmoop.2026.108528_bib21","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108528_bib10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1261\/rna.080368.124","article-title":"SF3B1: from core splicing factor to oncogenic driver","volume":"31","author":"Bak-Gordon","year":"2025","journal-title":"RNA"},{"issue":"suppl 15","key":"10.1016\/j.esmoop.2026.108528_bib11","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1200\/JCO.2021.39.15_suppl.9535","article-title":"Clinical characteristics of SF3B1 mutant (mut) uveal melanoma (UM) and response to immune checkpoint inhibition (ICI)","volume":"39","author":"Grimes","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108528_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115591","article-title":"Molecular determinants of survival in metastatic uveal melanoma: the impact of SF3B1 mutations","volume":"226","author":"del Carpio","year":"2025","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108528_bib13","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3390\/cells10092216","article-title":"Prognostic roles of BRAF, KIT, NRAS, IGF2R and SF3B1 mutations in mucosal melanomas","volume":"10","author":"Wr\u00f3blewska","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108528_bib14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.18632\/oncotarget.26584","article-title":"Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas","volume":"10","author":"Quek","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.esmoop.2026.108528_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejca.2021.08.015","article-title":"c-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma: a systematic review and one-arm meta-analysis","volume":"157","author":"Steeb","year":"2021","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108528_bib16","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41416-022-01942-z","article-title":"Clinical and genomic correlates of imatinib response in melanomas with KIT alterations","volume":"127","author":"Jung","year":"2022","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108528_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1470-2045(17)30180-8","article-title":"Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial","volume":"18","author":"Dummer","year":"2017","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.esmoop.2026.108528_bib18","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1200\/JCO.22.02018","article-title":"Initial evidence for the efficacy of naporafenib in combination with trametinib in NRAS-mutant melanoma: results from the expansion arm of a phase Ib, open-label study","volume":"41","author":"de Braud","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108528_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/2326-6066.CIR-25-0744","article-title":"RAS(ON) Multiselective inhibition drives antitumor immunity in preclinical models of NRAS-mutant melanoma","volume":"14","author":"Anastacio Da Costa Carvalho","year":"2026","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108528_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189521","article-title":"SF3B1 mutations in spliceosome-driven tumorigenesis: from splicing dysregulation to signaling network rewiring and therapeutic targeting","volume":"1881","author":"Yang","year":"2026","journal-title":"Biochim Biophys Acta Rev Cancer"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926024737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926024737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:42:08Z","timestamp":1792712528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926024737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2059702926024737"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108528","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anatomical location defines distinct molecular subtypes of mucosal melanoma","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108528"}}